M&A

Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?
Yahoo/Benzinga
Tue, 02/21/17 - 10:46 pm
Bristol-Myers Squibb
M&A
Carl Icahn
Torax Medical agrees to sell to Johnson & Johnson subsidiary
Bizjournals.com
Tue, 02/21/17 - 11:10 am
JNJ
Torax Medical
M&A
devices
Ethicon
J&J’s Ethicon to buy Torax Medical
Mass Device
Sat, 02/18/17 - 02:39 pm
JNJ
Ethicon
Torax Medical
M&A
devices
acid reflux
Sage Therapeutics Leads Biotech Movers on False Takeout Rumors
TheStreet.com
Fri, 02/17/17 - 11:04 am
SAGE Therapeutics
M&A
What's wrong with Sanofi's dealmaking approach? To hear Actelion tell it, plenty
Fierce Pharma
Fri, 02/17/17 - 10:01 am
Sanofi
Actelion
M&A
Bristol-Myers: Don’t Bet on a Pfizer Acquisition
Barron's
Thu, 02/16/17 - 10:07 am
Bristol-Myers Squibb
Pfizer
M&A
Integra offers to buy J&J's Codman business for $1.05 bln
Yahoo/Reuters
Wed, 02/15/17 - 10:25 am
Integra LifeSciences
JNJ
Codman
M&A
devices
neurosurgery
Hologic to buy Cynosure for $1.65 bln
Yahoo/Reuters
Tue, 02/14/17 - 07:37 pm
Hologic
Cynosure
M&A
devices
Bristol-Myers Squibb: Takeover Target?
Barron's
Tue, 02/14/17 - 07:35 pm
Bristol-Myers Squibb
M&A
Sanofi Sells 5 Over-the-Counter Drugs for $88M
Investopedia
Tue, 02/14/17 - 09:20 am
Sanofi
OTC
M&A
Ipsen
Allergan to buy Zeltiq Aesthetics for about $2.48 bln
Yahoo/Reuters
Mon, 02/13/17 - 10:14 am
Allergan
Zeltiq
M&A
Is Gilead Sciences Getting Ready for a Massive Acquisition?
Motley Fool
Mon, 02/13/17 - 10:12 am
Gilead Sciences
M&A
3 Reasons Johnson & Johnson's Actelion Deal Might Not Be Totally Crazy
Motley Fool
Mon, 02/13/17 - 09:54 am
JNJ
Actelion
M&A
Immunomedics, Seattle Genetics Lead Biotech Movers on Deal News
TheStreet.com
Fri, 02/10/17 - 09:52 am
Immunomedics
Seattle Genetics
M&A
solid tumors
Adcetris
Biotech voices: Allergan CEO Saunders isn’t slowing down on a brisk pace of biotech dealmaking
Endpoints
Thu, 02/9/17 - 09:48 am
Allergan
Pharma CEOs
Brent Saunders
M&A
Tesaro shares skyrocket on report of buyout interest from drugmakers
Bizjournals.com
Wed, 02/8/17 - 09:41 pm
Tesaro
M&A
Drugmaker Sanofi sees weak 2017 earnings, not in hurry for M&A
Yahoo/Reuters
Wed, 02/8/17 - 09:51 am
Sanofi
earnings
M&A
Covidien spinout Mallinckrodt closes $690m sale of nuclear imaging biz
Mass Device
Mon, 01/30/17 - 11:53 am
Covidien
Mallinckrodt
M&A
nuclear imaging
devices
Johnson & Johnson May Never Recoup Its Costs to Buy Actelion
Motley Fool
Sat, 01/28/17 - 02:29 pm
JNJ
Actelion
M&A
M&A is off to a hot start in 2017; Too bad we can’t say the same for gender parity
Endpoints
Sat, 01/28/17 - 02:26 pm
M&A
gender discrimination
Celgene
Delinia
JNJ
Actelion

Pages